MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    A new mutation in the C-terminal domain of the YY1 gene associated with Gabriele-de Vries syndrome.

    J. Gamez, M. Garcia-Hoyos, O. de Fabregues (Sant Just Desvern, Spain)

    Objective: To report a new mutation in the YY1 gene in a patient with Gabriele-de Vries syndrome, in which dystonia and choreoathetosis were the most…
  • MDS Virtual Congress 2021

    Botulinum injections for idiopathic cervical dystonia: a longitudinal study

    G. Yahalom, T. Fay-Karmon, V. Livneh, S. Israeli-Korn, L. Ephraty, S. Hassin-Baer (Jerusalem, Israel)

    Objective: In this retrospective longitudinal study, we explored the efficacy of repeated BT injection sessions for idiopathic cervical dystonia (ICD). Background: Botulinum toxin (BT) injections…
  • MDS Virtual Congress 2021

    Preliminary validation of an educational handbook for Parkinson’s disease patients in Brazil

    J. Bonfadini, D. Lima, A. Carneiro, S. Almeida, M. Rocha, M. Porto, P. Braga-Neto (Fortaleza, Brazil)

    Objective: To describe the development and preliminary validation of an educational handbook for Parkinson’s disease (PD) patients. Background: PD is a progressive, chronic and heterogeneous…
  • MDS Virtual Congress 2021

    Clinical and Economic Outcomes Associated with Dysphagia in Hospitalized Patients with Parkinson’s Disease

    D. Di Luca, E. Mcarthur, A. Willis, R. Martino, C. Marras (Toronto, Canada)

    Objective: To evaluate the outcomes associated with dysphagia in hospitalized patients with Parkinson's Disease and associated healthcare costs and utilization. Background: Dysphagia in Parkinson's Disease…
  • MDS Virtual Congress 2021

    Reproductive factors and risk of Parkinson’s disease in women: preliminary results from the French prospective cohort E3N.

    G. Pesce, F. Artaud, E. Roze, I. Degaey, A. Fournier, MC. Boutron-Ruault, A. Elbaz, M. Canonico (Villejuif, France)

    Objective: Objective: To evaluate whether reproductive factors and use of exogenous hormones are associated with the risk of Parkinson’s disease (PD) in women. Background: Background:…
  • MDS Virtual Congress 2021

    Intensive rehabilitation program for patients with functional motor disorders: 3-years’ experience.

    B. Martín Rojo, L. Martínez López, P. Rada Romero, C. Vicente Torcal, M. García Ibañez, B. Borda Nuin, M. Sanz Amador, C. Delgado Suarez, M. Kurtis Urra, I. Pareés Moreno (Madrid, Spain)

    Objective: To describe the clinical characteristics and the outcomes of a cohort of patients with functional movement disorders (FMD) who attended the FMD clinic of…
  • MDS Virtual Congress 2021

    Neural oscillations modulation during working memory in premanifest and early Huntington’s disease

    G. Bonassi, M. Semprini, P. Mandich, L. Trevisan, R. Marchese, G. Lagravinese, F. Barban, E. Pelosin, M. Chiappalone, D. Mantini, L. Avanzino (Genova, Italy)

    Objective: To test whether high-density electroencephalography (hdEEG) coupled to source localization allows for the identification of neuronal oscillations in specific frequency bands in patients with…
  • MDS Virtual Congress 2021

    Atypical gait in a patient with Huntington’s Disease (HD): Functional movement disorders in the spectrum of motor phenotypes in HD

    H. Leal Bailey, K. Block, E. Furr-Stimming, S. Chandra (Houston, USA)

    Objective: We describe a case of Huntington’s disease (HD) associated chorea and concurrent functional movement disorder (FMD). Background: HD is a neurodegenerative disorder characterized by…
  • MDS Virtual Congress 2021

    Validation of biomarkers in Huntington’s disease to support the development of disease-modifying therapies: a systematic review and critical appraisal scheme

    H. Tang, T. van Eimeren, C. Sampaio, T. Mestre (Ottawa, Canada)

    Objective: To review studies for disease progression biomarkers published in HD and evaluate their methodological quality in a standardized manner. Background: Huntington disease (HD) is a fatal autosomal dominant neurodegenerative condition that starts to manifest clinically around the 4th decade of life. There are promising novel genetic-based therapies under development intended to modify the disease trajectory. Valid…
  • MDS Virtual Congress 2021

    Neural correlates of executed compared to imagined writing and drawing movements. An fMRI study

    C. Gless, A. Baumann, I. Tödt, A. Knutzen, O. Granert, S. Wolff, JS. Becktepe, K. Witt, KE. Zeuner (Kiel, Germany)

    Objective: In this study we used functional magnetic resonance imaging (fMRI) to investigate whether motor imagery (MI) of handwriting and circle drawing activates a similar…
  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 132
  • Next Page »
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley